| 17alpha-ethynylestradiol | affects expression | ISO | RGD:736206 | 6480464 | Ethinyl Estradiol affects the expression of H2AFY mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736206 | 6480464 | Ethinyl Estradiol results in increased expression of H2AFY mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736206 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of H2AFY mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736206 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of H2AFY mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736206 | 6480464 | Tetrachlorodibenzodioxin affects the expression of H2AFY mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736206 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to H2AFY promoter] | CTD | PMID:19654925 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of H2AFY mRNA | CTD | PMID:21346803 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:736206 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of H2AFY mRNA | CTD | PMID:20188158 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of H2AFY mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:736206 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of H2AFY mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | increases expression | ISO | RGD:731902 | 6480464 | Aflatoxin B1 results in increased expression of H2AFY mRNA | CTD | PMID:22100608 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of H2AFY mRNA | CTD | PMID:18355885 |
| amitriptyline | affects expression | EXP | | 6480464 | Amitriptyline affects the expression of H2AFY mRNA | CTD | PMID:18355885 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of H2AFY mRNA | CTD | PMID:16483693 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of H2AFY promoter | CTD | PMID:22457795 |
| choline | multiple interactions | ISO | RGD:736206 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of H2AFY gene | CTD | PMID:20938992 |
| cis-ketoconazole | affects expression | EXP | | 6480464 | Ketoconazole affects the expression of H2AFY mRNA | CTD | PMID:18355885 |
| clofibrate | increases expression | ISO | RGD:736206 | 6480464 | Clofibrate results in increased expression of H2AFY mRNA | CTD | PMID:17585979 |
| clomipramine | affects expression | EXP | | 6480464 | Clomipramine affects the expression of H2AFY mRNA | CTD | PMID:18355885 |
| disodium selenite | increases expression | ISO | RGD:731902 | 6480464 | Sodium Selenite results in increased expression of H2AFY mRNA | CTD | PMID:18175754 |
| doxorubicin | affects response to substance | ISO | RGD:731902 | 6480464 | H2AFY protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| doxorubicin | decreases expression | ISO | RGD:736206 | 6480464 | Doxorubicin results in decreased expression of H2AFY mRNA | CTD | PMID:19277126 |
| folic acid | multiple interactions | ISO | RGD:736206 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of H2AFY gene | CTD | PMID:20938992 |
| imipramine | affects expression | EXP | | 6480464 | Imipramine affects the expression of H2AFY mRNA | CTD | PMID:18355885 |
| L-methionine | multiple interactions | ISO | RGD:736206 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of H2AFY gene | CTD | PMID:20938992 |
| paracetamol | increases expression | ISO | RGD:731902 | 6480464 | Acetaminophen results in increased expression of H2AFY mRNA | CTD | PMID:22230336 |
| pirinixic acid | decreases expression | ISO | RGD:736206 | 6480464 | pirinixic acid results in decreased expression of H2AFY mRNA | CTD | PMID:17426115 |
| propiconazole | decreases expression | ISO | RGD:736206 | 6480464 | propiconazole results in decreased expression of H2AFY mRNA | CTD | PMID:21278054 |
| raloxifene | affects expression | EXP | | 6480464 | Raloxifene affects the expression of H2AFY mRNA | CTD | PMID:16079270 |
| tamoxifen | affects expression | ISO | RGD:736206 | 6480464 | Tamoxifen affects the expression of H2AFY mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:731902 | 6480464 | tert-Butylhydroperoxide results in decreased expression of H2AFY mRNA | CTD | PMID:15336504 |
| valproic acid | decreases expression | ISO | RGD:731902 | 6480464 | Valproic Acid results in decreased expression of H2AFY mRNA | CTD | PMID:19101580 |